Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy

The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invasive meningococcal disease (IMD) and may potentially offer protection against strains belonging to non-B serogroups. This study aimed to evaluate the ability of 4CMenB-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: Fazio, Cecilia, Biolchi, Alessia, Neri, Arianna, Tomei, Sara, Vacca, Paola, Ambrosio, Luigina, Palmieri, Annapina, Mori, Elena, La Gaetana, Rita, Pizza, Mariagrazia, Giuliani, Marzia Monica, Serino, Laura, Stefanelli, Paola
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2021
Soggetti:
Short Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189125/
https://ncbi.nlm.nih.gov/pubmed/33522380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1855951
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi